← Back to Vaccine Database

Ad5-nCoV-IH

Viral vector (Non-replicating) vaccine · VDDBV0052

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
ApprovedPhase 4 reached

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials4

NCT IDPhaseDisease / Condition
NCT05124561 Phase 3COVID-19
NCT05169008 Phase 3COVID-19
NCT05204589 Phase 3COVID-19
NCT05303584 ApprovedCOVID-19